Using IVIG to treat gastrointestinal autoimmune neuropathy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients suffering from gastrointestinal motility disorders, particularly those with autoimmune findings who have not responded to standard treatments. It aims to document the clinical observations and responses of these patients to intravenous immunoglobulin (IVIG) therapy. Patients will complete standardized surveys to assess their gastrointestinal symptoms before and after receiving IVIG. The study seeks to identify the effectiveness of IVIG in managing symptoms of autoimmune gastrointestinal neuropathies.

Why it matters

Who can join: the full rules

Inclusion Criteria: Patient with otherwise refractory symptoms of gastrointestinal (GI) motor disorders.

\-

Exclusion Criteria: Inability to receive intravenous immunoglobulin.

\-

Where it's running

• University of Louisville
  Louisville, Kentucky, United States Recruiting

Study contacts

• Study coordinator: Thomas L Abell, MD
• Email: thomas.abell@louisville.edu
• Phone: (502)852-6991

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Home-use Erchonia EVRL laser for temporary relief of idiopathic peripheral neuropathy foot pain

  This study will test whether a home-use Erchonia EVRL laser can provide temporary relief of foot pain for adults with idiopathic peripheral neuropathy.

  Recruiting Erchonia Corporation · Miramar, Florida · NCT06912646

• Gastric-focused ultrasound to see if it changes stomach activity and symptoms

  This study tests whether noninvasive stomach-focused ultrasound can alter post-meal stomach electrical activity and symptoms in adults with gastroparesis or delayed gastric emptying, using a sham control in a crossover design.

  Recruiting University of Texas at Austin · Austin, Texas · NCT07851727

• Gastric emptying and feeding tolerance in ICU patients by vasopressor dose

  This study tests whether vasopressor dose affects how well stomach contents empty during tube feeding in critically ill patients.

  Recruiting Başakşehir Çam & Sakura City Hospital · Istanbul · NCT07802379

• Virtual poetry workshops to boost well-being for people with digestive symptoms

  This study tests whether participating in online poetry workshops can improve emotional well-being for adults with chronic digestive symptoms and anxiety or depression.

  Recruiting Ohio State University · Columbus, Ohio · NCT07717541

• Collecting clinical, nerve conduction, electromyography, and ultrasound data in adults with peripheral neuropathy

  This project will see if collecting detailed clinical, nerve conduction, electromyography, and ultrasound data from adults with peripheral neuropathy during routine visits can improve understanding and care.

  Recruiting Casa di Cura Dott. Pederzoli · Peschiera del Garda, Verona · NCT07437989

• Blood microRNA markers for chemotherapy-related peripheral nerve damage in lung and colorectal cancer

  This study will test whether levels of tiny blood molecules called microRNAs can predict how often and how badly patients with lung or colorectal cancer get nerve damage from certain chemotherapies.

  Recruiting University Hospital, Clermont-Ferrand · Clermont-Ferrand · NCT07427537

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.